Manufacturers Life Insurance Company, The Clovis Oncology, Inc. Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.63 - $2.96 $33,390 - $156,880	-53,000 Closed	0 $0
Q1 2022 Aug 11, 2023	BUY	$1.43 - $3.14 $75,790 - $166,420	53,000 New	53,000 $107,000
Q1 2022 May 20, 2022	SELL	$1.43 - $3.14 $14,274 - $31,343	-9,982 Reduced 15.85%	53,000 $107,000
Q4 2021 Feb 16, 2022	BUY	$2.7 - $4.76 $3,407 - $6,007	1,262 Added 2.04%	62,982 $171,000
Q3 2021 Nov 12, 2021	BUY	$4.06 - $5.8 $17,600 - $25,143	4,335 Added 7.55%	61,720 $275,000
Q2 2021 Aug 12, 2021	BUY	$5.02 - $7.05 $46,495 - $65,297	9,262 Added 19.25%	57,385 $333,000
Q1 2021 May 03, 2021	SELL	$4.81 - $10.34 $17,373 - $37,348	-3,612 Reduced 6.98%	48,123 $338,000
Q4 2020 Feb 12, 2021	BUY	$4.13 - $6.41 $18,254 - $28,332	4,420 Added 9.34%	51,735 $248,000
Q3 2020 Nov 09, 2020	BUY	$4.82 - $7.72 $18,879 - $30,239	3,917 Added 9.03%	47,315 $276,000
Q2 2020 Aug 10, 2020	BUY	$5.69 - $9.69 $58,276 - $99,244	10,242 Added 30.89%	43,398 $305,000
Q1 2020 May 15, 2020	BUY	$3.77 - $11.0 $8,052 - $23,496	2,136 Added 6.89%	33,156 $211,000
Q4 2019 Feb 14, 2020	SELL	$3.0 - $16.43 $1,644 - $9,003	-548 Reduced 1.74%	31,020 $323,000
Q3 2019 Nov 12, 2019	BUY	$3.93 - $15.35 $2,806 - $10,959	714 Added 2.31%	31,568 $126,000
Q2 2019 Aug 14, 2019	SELL	$12.81 - $25.67 $3,932 - $7,880	-307 Reduced 0.99%	30,854 $459,000
Q1 2019 May 13, 2019	BUY	$17.66 - $30.28 $37,562 - $64,405	2,127 Added 7.33%	31,161 $774,000
Q4 2018 Feb 14, 2019	SELL	$11.63 - $32.67 $23,260 - $65,340	-2,000 Reduced 6.44%	29,034 $522,000
Q3 2018 Nov 14, 2018	SELL	$29.37 - $49.48 $122,414 - $206,232	-4,168 Reduced 11.84%	31,034 $911,000
Q2 2018 Aug 14, 2018	BUY	$42.06 - $62.4 $108,683 - $161,241	2,584 Added 7.92%	35,202 $1.6 Million
Q1 2018 May 15, 2018	SELL	$50.12 - $67.72 $43,504 - $58,780	-868 Reduced 2.59%	32,618 $1.72 Million
Q4 2017 Feb 08, 2018	BUY	$57.69 - $84.58 $13,037 - $19,115	226 Added 0.68%	33,486 $2.28 Million
Q3 2017 Nov 14, 2017	BUY	$67.17 - $84.81 $2.23 Million - $2.82 Million	33,260	33,260 $2.74 Million

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account